Horizon 2020 - New Innovative Medicines Initiative (IMI) Call
Research and Transfer Service
31 January 2020
Submission deadline for stage one: 21 April 2020
Call 20 of IMI have been launched and include the following topics:
- Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in Psoriatic Arthritis
- Innovations to accelerate vaccine development and manufacture
- Real-world clinical implementation of liquid biopsy
- Tumour plasticity
- Proton versus photon therapy for oesophageal cancer – a trimodality strategy
- Handling of protein drug products and stability concerns
- Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
Note: This topic is part of the IMI Antimicrobial Resistance (AMR) Accelerator programme
For further information, please visit the call webpage and contact Ms. Martina Pestoni.
